DNLI stock

Denali Therapeutics Inc (DNLI) financials · $2.11B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Denali Therapeutics Inc (DNLI) $2.11B cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/AN/A
Operating Income-$555.3M-$487.3M
Net Income-$512.5M-$422.8M
EPS (Diluted)-$2.97-$2.57
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.14B$1.37B
Current Assets$900.7M$864.4M
Cash & Equivalents$205.3M$175.0M
Inventory$0N/A
PP&E$52.4M$55.2M
Total Liabilities$131.1M$144.5M
Current Liabilities$98.4M$102.2M
Shareholders' Equity$1.01B$1.23B
Retained Earnings-$2.05B-$1.54B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$412.6M-$347.7M
CapEx$9.50M$15.9M
Investing Cash Flow$255.3M-$88.8M
Financing Cash Flow$189.2M$484.3M
Net Change in Cash$31.9M$47.9M
Free Cash Flow-$422.1M-$363.6M
These statements as JSON? API free 100/day

FAQ

What is DNLI P/E and revenue?

Denali Therapeutics Inc (DNLI) $2.11B cap.

What is DNLI revenue?

DNLI income-statement cache has no revenue figure yet.

Is DNLI profitable?

Denali Therapeutics Inc last cached net income is -$512.5M (FY2025).

What are DNLI total assets?

Denali Therapeutics Inc last cached total assets are $1.14B (FY2025).

What is DNLI free cash flow?

Denali Therapeutics Inc last cached free cash flow is -$422.1M (FY2025).

Not investment advice. Cached statements, not a live tape.